|
|
Volumn 29, Issue 1, 2011, Pages 27-33
|
|
The problems with today's pharmaceutical business-an outsider's view
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DENDRITIC CELL VACCINE;
ERLOTINIB;
ORPHAN DRUG;
ROSIGLITAZONE;
COMMERCIAL PHENOMENA;
DIABETES MELLITUS;
DRUG COST;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG USE;
HEALTH CARE POLICY;
HUMAN;
LEADERSHIP;
MEDICARE;
NONHUMAN;
NOTE;
PATENT;
PRIORITY JOURNAL;
PROSTATE CANCER;
UNITED STATES;
BIOMEDICAL RESEARCH;
BIOTECHNOLOGY;
DRUG INDUSTRY;
DRUGS, GENERIC;
ORPHAN DRUG PRODUCTION;
|
|
EID: 78651297594
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.1748 Document Type: Note |
|
Times cited : (88)
|
|
References (10)
|
